GlassScriptPhysician profile
Thomas A Herzog
NPI 1366466526
$2,490.03
in general payments reported to CMS, 2019-2025
8 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $125 · 2021: $131 · 2022: $321 · 2023: $1,248 · 2024: $396 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878 · Travel and Lodging: $711 · Education: $156 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.16 |
| Travel and Lodging | $711.43 |
| Education | $156.06 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,547.51 | 2022-2024 | Da Vinci Surgical System |
| Takeda Pharmaceuticals U.S.A., INC. | $275.00 | 2020-2022 | |
| Boston Scientific Corporation | $140.36 | 2024 | Spyglass Discover |
| Avanos Medical | $130.81 | 2019 | |
| Innovation Technologies INC | $130.58 | 2021 | |
| Glaxosmithkline, LLC. | $127.40 | 2023 | Zejula |
| Corcept Therapeutics | $117.60 | 2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Herzog listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.